Tracked deals
3258
3258 tracked deals across 2008-2026.
Tracked deals
3258
3258 tracked deals across 2008-2026.
Buyer mix
Mixed buyer set
3177 pe · 1918 strategic
Top trend
Volume peaked in 2021
578 tracked deals announced in 2021.
Buyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| NMS Capital | 63 | Private equity firm focused on lower middle market invest... | PE |
| Gryphon Investors | 28 | Middle-market private equity firm and sponsor; provides c... | PE |
| The Riverside Company | 27 | Global private equity firm focused on the smaller end of ... | PE |
| Revelstoke Capital Partners | 26 | Healthcare-focused private equity firm that partners with... | PE |
| Sheridan Capital Partners | 23 | Chicago-based healthcare private equity firm focused on l... | PE |
| HCAP Partners | 22 | Southern California-based private equity and mezzanine de... | PE |
| H.I.G. Capital | 21 | Global alternative investment firm providing equity and d... | PE |
| InTandem Capital Partners | 21 | Private equity firm focused on investing in and growing h... | PE |
| Linden Capital Partners | 21 | Healthcare-focused private equity firm investing in middl... | PE |
| Ampersand Capital Partners | 20 | Middle-market private equity firm focused on growth-orien... | PE |
Last 10 years
Supporting Data
An affiliate of Peak Rock Capital completed its acquisition of Asembia LLC and its related entities. Asembia provides end-to-end technology-enabled commercialization solutions to the specialty pharma industry, including patient support HUB services, specialty distribution, data services, pharmacy software, and GPO solutions.
Momentum Life Sciences announced a strategic growth investment from Parthenon Capital. Financial terms were not disclosed, and Momentum’s existing leadership team will remain significant shareholders. The investment is intended to accelerate Momentum’s growth and support planned strategic acquisitions across the specialty-therapy commercialization ecosystem.
Select Medical Holdings announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The transaction values Select Medical at approximately $3.9 billion and was made effective July 1, 2026, with Select Medical’s stock ceasing to trade.
Experity, an on-demand healthcare technology platform for U.S. urgent care clinics, announced it has acquired Exdion Healthcare, an AI-driven chart-to-cash revenue cycle management (RCM) SaaS platform. The acquisition is intended to unify clinical, operational, and financial workflows with AI to accelerate reimbursement, reduce manual work, and improve denials and payment velocity. Exdion’s insurance-focused affiliate is excluded from the transaction and will continue to operate independently.
Integrated Water Services (IWS) acquired Tetrasolv Filtration to expand advanced water treatment, specialized filtration/media services, rentals, and field support capabilities. The deal, which closed on June 22, 2026, positions the combined organization to deliver turnkey wastewater treatment solutions for industrial and municipal mid-market customers.
EBI, an Avista Healthcare Partners portfolio company, announced the acquisition of Xstim, a division of Precision Medical Products Inc. Xstim develops a next-generation, wearable, non-invasive spine fusion electrical stimulation therapy intended to support lumbar spinal fusion and related bone-healing applications.
Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.
Simulations Plus, Inc. has entered into a definitive agreement to be acquired by affiliates of Altaris in an all-cash transaction valued at approximately $375 million. The deal is expected to combine Simulations Plus with Altaris portfolio company Chemical Computing Group (CCG) and is currently expected to close in Q4 2026, subject to customary approvals.
Abarca Health and LucyRx announced a strategic combination to create an independent pharmacy benefit manager (PBM) designed to serve commercial and government clients at scale. The combined company will provide prescription services to more than 9 million members and will operate the Abarca and LucyRx brands as wholly owned subsidiaries of Healthcare Revolution Partners at closing, expected in Q3 2026.
Thurston Group, a Chicago-based private equity firm, announced the formation of a national dental support platform by uniting SGA Dental Partners, Gen4 Dental Partners, and Modis Dental Partners under the SGA Dental Partners brand. The combined platform will serve 250+ locations and 500+ dentists across 26 states, combining doctor recruiting, professional development, and implant/specialty support capabilities.
Med-Metrix entered into a definitive agreement to acquire CanAide, a provider of Medicaid eligibility and enrollment services and RCM automation solutions. The deal aims to strengthen Med-Metrix’s end-to-end revenue cycle platform by extending front-end capabilities, improving patient access, and enhancing net revenue yield for health system clients.
Chariot Capital Group completed its acquisition of Laser Clinics UK, a leading provider of laser, skin, and aesthetic treatments in the United Kingdom. The deal carves out the UK operations as an independent platform and is intended to be supported for continued growth through investments in its clinic footprint, technology, and talent.
GNI Group Co., Ltd. has announced an agreement to acquire 100% of the shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone for approximately ¥44.8 billion. The deal will make Ayumi a wholly owned subsidiary of GNI Group and materially expand Ayumi’s commercial footprint in Japan.
Global investment firm Carlyle has signed a definitive agreement to acquire up to 100% of Chung Ho Group, a Korean home and healthcare appliance rental platform. The deal is expected to close in the third quarter of 2026, subject to regulatory approvals and customary closing conditions.
Sheridan Capital Partners has completed a majority recapitalization of Tres Health, a health insurance services provider focused on the self-insured space. The founders sold their stake while continuing to lead the company as senior management, and financial terms were not disclosed.
Micro-Dyn Medical Systems, LLC announced its acquisition of CMSPricer, a Dallas-based healthcare claims pricing and contract management technology provider. The deal is made in partnership with The Brydon Group and will add payer/provider contract management and commercial claims pricing capabilities to Micro-Dyn’s platform. CMSPricer founder and CEO Clanton Lynch will join Micro-Dyn as Executive Vice President of Strategy.
Aligned Fitness Holdings, a multi-unit Club Pilates franchisee, acquired six Club Pilates studios in central New Jersey as part of its entry into the Garden State and expansion of its footprint to 61 studios nationwide. The acquisitions include two studios owned by entrepreneur Gary Laden and four studios operated by Karen and Todd Spidare. Financial terms were not disclosed, and the integration is expected to follow the close.
Hidden River Strategic Capital announced an investment in Northstar Senior Living to support Northstar’s merger with Alta Senior Living, creating a combined Northstar Senior Living platform. Hidden River’s financing consisted of debt and convertible preferred equity intended to help integrate operations, invest in technology, and expand the company’s geographic reach.
Soleo Health acquired Realo Specialty Care Pharmacy and BluHaven Management from parent company Realo Drugs. The deal expands Soleo Health’s presence in the Mid-Atlantic region, adding a specialty pharmacy in Morrisville, North Carolina and an ambulatory infusion center in Raleigh, North Carolina.
Discovery Behavioral Health (DBH) entered a major restructuring after defaulting on roughly $280 million of debt, following a dispute over its debt-to-earnings calculations. Lenders led by HPS Investment Partners and Capital One seized control, ousting the board and CEO and effectively converting debt into ownership, with a new CEO (Pete Clarke) introduced in the subsequent announcement.
KKR acquired Lighthouse Learning Group in a deal announced May 11, 2026 with undisclosed terms. The acquisition expands KKR’s education footprint and is expected to follow a typical private-equity operating pattern focused on near-term profitability improvements.
Warburg Pincus made a growth investment in Cornerstone Caregiving, a Waco, Texas-based home-based care provider serving seniors across the United States. Monroe Capital provided lead-arranged unitranche/senior credit financing (terms undisclosed) to support the investment, reflecting continued private equity interest in non-acute, aging-in-place care delivery models.
CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide API CDMO, to expand its peptide development and manufacturing capabilities. The deal adds manufacturing capacity in North Augusta, South Carolina and Shanghai, China, strengthening CordenPharma’s upstream and downstream peptide API footprint and geographic flexibility for global customers.
Frazier Healthcare Partners has completed its acquisition of Altruix, a behavioral health-focused specialty pharmacy platform headquartered in Hunt Valley, Maryland. The deal adds a high-touch clinical care model spanning medication adherence programs, specialized packaging, and access to complex therapies for patients with severe mental illness, substance use disorders, and intellectual and developmental disabilities.
Align Capital Partners (ACP) acquired Heritage Imaging, a Boise-based provider of mobile diagnostic imaging services to hospitals and healthcare facilities across rural and underserved markets in the United States. CEO Dr. Steve Coppess will continue to lead the business alongside the current management team as ACP pursues a broader outsourced imaging roll-up strategy with additional modalities and adjacent-market acquisitions.
Stonepeak has entered into a definitive agreement to acquire a majority stake in Australia’s Estia Health, with Axight Capital as a consortium partner. The consortium plans to take the ASX-listed residential aged care operator private, with expected closing in late 2026 (or mid-2025 per another report), subject to regulatory approvals.
Swoop, a healthcare engagement platform backed by New Mountain Capital, announced the acquisition of Nimble, a prescription management platform used by independent pharmacies across the United States. Nimble enables patients to fill, refill, pay for, and manage prescriptions, and its technology is intended to help Swoop connect pharmacy/prescription signals to life sciences engagement and improved therapy adherence.
Goldentree Asset Management became the majority owner of Quorum Health in 2024 as the hospital chain emerged from bankruptcy. Quorum announced plans to shift from a private-equity-backed for-profit structure to a nonprofit model managed by QKA Health Corporation (doing business as Healthside Partners), subject to regulatory approval and expected to be finalized in Fall 2026.
Avista Healthcare Partners and Belgium-based Damier Group have signed a definitive agreement to acquire Germany-based vitamins, minerals and supplements (VMS) platform sanotact Group GmbH. The deal combines Avista’s consumer healthcare focus with sanotact’s full-service CDMO capabilities and branded supplement portfolio serving customers across roughly 80 international markets.
Bailey & Company announced it advised benefitbay on its strategic investment from Ten Coves Capital. The investment will fund the next phase of benefitbay’s growth, including payments infrastructure build-out, expanded carrier and payroll integrations, and enhancements to broker enablement tools for ICHRA administration.
Orion Legal, an MSO backed by Uplift Investors, acquired Hughes Coleman Injury Lawyers, a Tennessee-based personal injury practice with about $50 million in annual revenue. The acquisition adds roughly 40 attorneys and support staff to Orion’s platform and represents Orion’s first significant entry into the Tennessee market.
Integrated Home Care Services announced its acquisition of Dina Care, an AI-enabled care coordination and referral management platform. The combined platform is intended to expand Integrated’s in-home benefit management capabilities by pairing its utilization management, provider network, referral management and fulfillment expertise with Dina’s AI-driven workflow automation and digital workforce tools.
Lexitas Pharma Services (a QHP Capital portfolio company) acquired Erie Retina Research, along with CASExERIE and the assets of Element Erie: Imaging & Reading Center, to expand its retina-focused clinical research platform. Erie Retina Research will operate as a wholly owned subsidiary of Lexitas, CASExERIE will continue to operate within Erie Retina Research, and Element Erie’s imaging/reading capabilities will be integrated into Lexitas’ trial services.
H.I.G. Bayside Capital Europe provided a £90m unitranche term loan to refinance Lifeways Group’s existing debt. The five-year facility supports Lifeways’ continued growth strategy in high-acuity support services across the United Kingdom.
Salt Creek Capital has acquired MML Diagnostics Packaging, Inc. (MML), a contract manufacturer and packaging partner for in-vitro diagnostic devices and single-use medical devices. The investment is intended to support MML’s continued growth while preserving its customer-first culture and operational discipline.
Menlo Ventures is leading Nourish’s $100 million Series C to scale access to insurance-covered virtual nutrition counseling. Nourish connects patients with registered dietitians nationwide and automates parts of care delivery (credentialing, insurance verification, documentation) with AI-enabled workflows.
Procare Ambulance of Maryland entered into a strategic partnership backed by Prodos Capital and Manolin Investment Group, with growth capital also provided by Tecum Capital, Genesis Park Capital, and SharpVue Capital. The investment is intended to accelerate Procare’s geographic expansion (including into Virginia) and further develop its Mobile Integrated Healthcare (MIH) program, along with workforce, fleet, and service scaling.
Arcadea Group announced the acquisition of Sofis, a Brazil-based provider of mission-critical healthcare software focused on hemotherapy and cell therapy. Sofis serves more than 300 healthcare institutions and provides software for blood bank and transfusion services, cell therapy, hospital management, and related diagnostic/ERP and business intelligence use cases.
Galloway Capital Partners (together with its affiliates) announced it accumulated an ownership stake of approximately 8.42% in WW International, Inc. Galloway argues WW is undervalued and points to the company’s turnaround/restructuring, growing clinical business, and the value of its member ecosystem and data.
Lafayette Instrument, LLC acquired Sutter Instrument Corp. Terms were not disclosed. The deal expands Lafayette’s life sciences instrumentation product offerings and strengthens its support for universities and research institutions working in electrophysiology and neuroscience.
CVS Health’s subsidiary Omnicare received U.S. Bankruptcy Court approval to sell its business to GenieRx Holdings LLC in a transaction valued at $250 million. GenieRx is a joint partnership between Milrose Capital LLC and Integro Asset Management LLC (doing business as Integro Healthcare Services). The transaction is expected to close later in 2026, subject to regulatory approval and customary closing conditions.
Eir Partners acquired a controlling interest in QuartzBio, a life science technology company providing connected sample and biomarker intelligence for clinical-stage biopharma. The growth investment is intended to help QuartzBio expand its biomarker intelligence offerings and scale operations, while accelerating platform enhancements such as AI-driven automation, interoperability, and enterprise scalability.
H.I.G. Capital’s portfolio company Avanta Salud Integral (“Avanta”) has signed a definitive agreement to acquire Vitaly Group (“Vitaly”), a leading occupational health and safety (OHS) services provider in Iberia. The combined group is expected to serve more than 240,000 clients and cover approximately 4 million protected workers across 505 centers, with Vitaly’s advanced AI capabilities supporting integration and international expansion.
PeterMD, a direct-to-consumer telehealth and precision medicine platform, announced a majority equity investment from Lorient to accelerate growth of its “Medicine 3.0” platform. The partnership also involves Emanate, and PeterMD will add David Prokupek to its board as Executive Chair.
LEARN Behavioral (backed by Gryphon Investors) acquired Little Leaves Behavioral Services from FullBloom, closing the deal on May 11, 2026. The transaction adds Little Leaves’ 18 center-based ABA programs across Maryland, Virginia, and Florida to LEARN’s existing platform, strengthening LEARN’s density in the Mid-Atlantic and Southeast.
JoyBridge Kids acquired two large autism clinics formerly operated by A Bridge to Achievement in Charlotte and Winston-Salem, North Carolina. The acquisitions support JoyBridge’s first adult service line, launching an Adult Daily Living (ADL) program within the acquired clinic sites. Deal terms were not disclosed, and the companies have not issued a joint press release as of publication.
GI Partners completed its acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories, creating an independent advanced therapy manufacturing company, Rose BioSolutions. Rose BioSolutions will provide end-to-end cell and gene therapy development and manufacturing, covering plasmid DNA, viral vectors, cell therapy production, and cellular starting materials.
Chiron Real Estate Inc. (NYSE: XRN) entered into an agreement for up to a $100 million delayed-draw, convertible perpetual preferred equity investment led by Maewyn Capital Partners. The financing is designed to support Chiron’s portfolio repositioning toward higher-return healthcare real estate opportunities, including senior housing, with funds drawn over six months subject to closing conditions.
Blue Ridge Associates acquired Economic Group Pension Services (EGPS) to expand its retirement plan administration and compliance platform. The deal grows Blue Ridge’s scale with EGPS bringing more than 260 employees, about 7,200 retirement plans, and over $17 billion in assets under administration.
Amulet Capital Partners announced it has acquired TFP Fertility Group, a fertility care provider operating clinics across the UK and Northern Europe, from Benefit Street Partners. TFP will continue to operate under the TFP brand with no changes to its clinical leadership, led by CEO Jude Fleming.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.